Goodman, WK; Grice, DE; Lapidus, KA; Coffey, BJ (September 2014). “Obsessive-compulsive disorder.”. The Psychiatric clinics of North America37 (3): 257–67. doi:10.1016/j.psc.2014.06.004. PMID25150561.
Grant JE (2014-08-14). “Clinical practice: Obsessive-compulsive disorder.”. The New England Journal of Medicine371 (7): 646–53. doi:10.1056/NEJMcp1402176. PMID25119610.
Esalatmanesh S, Abrishami Z, Zeinoddini A, Rahiminejad F, Sadeghi M, Najarzadegan MR, Shalbafan MR, Akhondzadeh S. (2016-08-04). “Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.”. en:Psychiatry and Clinical Neurosciences.. doi:10.1111/pcn.12430. PMID27488081.
Palatnik A, Frolov K, Fux M, Benjamin J (2001). “Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder”. Journal of Clinical Psychopharmacology21 (3): 335–339. doi:10.1097/00004714-200106000-00014. PMID11386498.
Goodman, WK; Grice, DE; Lapidus, KA; Coffey, BJ (September 2014). “Obsessive-compulsive disorder.”. The Psychiatric clinics of North America37 (3): 257–67. doi:10.1016/j.psc.2014.06.004. PMID25150561.
Grant JE (2014-08-14). “Clinical practice: Obsessive-compulsive disorder.”. The New England Journal of Medicine371 (7): 646–53. doi:10.1056/NEJMcp1402176. PMID25119610.
Esalatmanesh S, Abrishami Z, Zeinoddini A, Rahiminejad F, Sadeghi M, Najarzadegan MR, Shalbafan MR, Akhondzadeh S. (2016-08-04). “Minocycline combination therapy with fluvoxamine in moderate-to-severe obsessive-compulsive disorder: A placebo-controlled, double-blind, randomized trial.”. en:Psychiatry and Clinical Neurosciences.. doi:10.1111/pcn.12430. PMID27488081.
Fux M, Levine J, Aviv A, Belmaker RH (1996). “Inositol treatment of obsessive-compulsive disorder”. American Journal of Psychiatry153 (9): 1219–21. PMID8780431.
Palatnik A, Frolov K, Fux M, Benjamin J (2001). “Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder”. Journal of Clinical Psychopharmacology21 (3): 335–339. doi:10.1097/00004714-200106000-00014. PMID11386498.